HAGER INVESTMENT MANAGEMENT SERVICES, LLC
Position in NVO — Novo Nordisk A S
CIK 2026645
NEW LONDON, NH
Position in NVO
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$28,859
+$3,722 QoQ
Shares Held
602
-12.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,157
of 1,348 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HAGER INVESTMENT MANAGEMENT SERVICES, LLC holds $12,489,605 across 12 Drug Manufacturers - General names. NVO ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,593 | $5,508,982 | |
| 2 | MRK |
Merck & Co., Inc.
|
14,795 | $1,901,157 | |
| 3 | BIIB |
Biogen Inc.
|
7,381 | $1,594,738 | |
| 4 | ABBV |
AbbVie Inc.
|
5,407 | $1,360,617 | |
| 5 | AMGN |
Amgen Inc
|
3,476 | $1,258,729 | |
| 6 | JNJ |
Johnson & Johnson
|
1,877 | $476,701 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,431 | $307,132 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
602 | $28,859 |
All Filings in NVO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,859 | 602 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $25,137 | 684 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $34,801 | 684 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $29,409 | 530 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $36,580 | 530 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $36,803 | 530 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $45,590 | 530 | Shares | Sole | 2025-01-27 | |
| No filing history on record for this holder in this stock. | ||||||